Bacil Pharma Ltd — Results, 26-05-2025: Result

Bacil Pharma has announced a board meeting to approve the financial results for the quarter and half-year. The company reported total revenue of ₹66.14 lakh for the year, with a profit after tax of ₹40.41 lakh, reversing losses from the previous year. Other comprehensive income was marginally negative at ₹(0.36) lakh. Equity share capital increased to ₹1397.02 lakh from ₹589 lakh due to recent allotments. Cash and cash equivalents surged to ₹285.73 lakh. The statutory auditor issued an unmodified opinion but highlighted outstanding loans and advances lacking confirmations, which may affect recoverability assessment. This reflects improved financial health and capital infusion, supporting shareholder value.